Skip to main content
SpringerLink
Log in

Absence of a relationship between vitamin D and Graves’ orbitopathy

  • Brief Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Data sets generated during and/or analyzed during the present study available from the corresponding author upon request.

References

  1. Gallo D, Mortara L, Gariboldi MB, Cattaneo SAM, Rosetti S, Gentile L, Noonan DM, Premoli P, Cusini C, Tanda ML, Bartalena L, Piantanida E (2020) Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest 43:413–429

    Article  CAS  PubMed  Google Scholar 

  2. Charoenngam N, Holick MF (2020) Immunologic effects of vitamin D on human health and disease. Nutrients 12:2097

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH (2022) Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 376:e066452

    Article  PubMed  PubMed Central  Google Scholar 

  4. Khamisi S, Lundqvist M, Rasmusson AJ, Engström BE, Karlsson FA, Ljunggren Ö (2023) Vitamin D and bone metabolism in Graves’ disease: a prospective study. J Endocrinol Invest 46:425–433

    Article  CAS  PubMed  Google Scholar 

  5. Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marino M, Vaidya B, Wiersinga WM (2021) The 2021 European group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves’ orbitopathy. Eur J Endocrinol 185:G43–G67

    Article  CAS  PubMed  Google Scholar 

  6. Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, Posarelli C, Figus M, Marcocci C, Marinò M (2023) Anti-nuclear autoantibodies in Graves' disease and Graves’ orbitopathy. J Endocrinol Invest 46:337–344

    Article  CAS  PubMed  Google Scholar 

  7. Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML (2020) Epidemiology, natural history, risk factors, and prevention of Graves’ orbitopathy. Front Endocrinol (Lausanne) 11:615993

    Article  PubMed  Google Scholar 

  8. Nicolì F, Lanzolla G, Mantuano M, Ionni I, Mazzi B, Leo M, Sframeli A, Posarelli C, Maglionico MN, Figus M, Nardi M, Marcocci C, Marinò M (2021) Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy. J Endocrinol Invest 44:581–585

    Article  PubMed  Google Scholar 

  9. Lanzolla G, Menconi F, Nicolì F, Posarelli C, Maglionico MN, Figus M, Nardi M, Marcocci C, Marinò M (2021) Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study. J Endocrinol Invest 44:2575–2579

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Planck T, Shahida B, Malm J, Manjer J (2018) Vitamin D in Graves’ disease: levels, correlation with laboratory and clinical parameters, and genetics. Eur Thyroid J 7:27–33

    Article  CAS  PubMed  Google Scholar 

  11. Gallo D, Mortara L, Veronesi G, Cattaneo SA, Genoni A, Gallazzi M, Peruzzo C, Lasalvia P, Moretto P, Bruno A, Passi A, Pini A, Nauti A, Lavizzari MA, Marinò M, Lanzolla G, Tanda ML, Bartalena L, Piantanida E (2022) Add-on effect of selenium and vitamin D combined supplementation in early control of Graves’ disease hyperthyroidism during methimazole treatment. Front Endocrinol (Lausanne) 13:886451

    Article  PubMed  Google Scholar 

  12. Appunni S, Rubens M, Ramamoorthy V, Saxena A, Tonse R, Veledar E, McGranaghan P (2021) Association between vitamin D deficiency and hypothyroidism: results from the national health and nutrition examination survey (NHANES) 2007–2012. BMC Endocr Disord 21:224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by funds from the University of Pisa to M.M. (Fondi di Ateneo 2019, 2020 and 2021 and Progetti di Ricerca di Ateneo 2018-2019, no. 539901).

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    G. Lanzolla, L. Di Matteo, S. Comi, G. Cosentino, F. Menconi & M. Marinò

  2. Department of Surgical, Medical and Molecular Pathology, Ophthalmology Unit I, University of Pisa and University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    M. N. Maglionico, C. Posarelli & M. Figus

Authors
  1. G. Lanzolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Di Matteo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Cosentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Menconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. N. Maglionico
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Posarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Figus
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Marinò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Marinò.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. Michele Marinò is a member of the Journal of Endocrinological Investigation Editorial Board.

Ethical approval

This study was performed according to Institutional guidelines. Approval was not required. All procedure performed in the study involving human participants were in accordance with the ethical standards of the Trust and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the individual participant included in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lanzolla, G., Di Matteo, L., Comi, S. et al. Absence of a relationship between vitamin D and Graves’ orbitopathy. J Endocrinol Invest 46, 1717–1721 (2023). https://doi.org/10.1007/s40618-023-02017-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-023-02017-3

Keywords

Search

Navigation